The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions

Nephron - Experimental Nephrology

Volumn 109, Issue 2, 2008, Pages

  Yao, Qiang ^a,b   Pawlaczyk, Krzysztof ^a,c   Ayala, Ernesto Rodríguez ^a   Styszynski, Arkadiusz ^c   Breborowicz, Andrzej ^c   Heimburger, Olof ^a   Qian, Jia Qi ^b   Stenvinkel, Peter ^a   Lindholm, Bengt ^a   Axelsson, Jonas ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Collagen; Dialysis solutions; Fibrosis; Peritoneal dialysis rat model; Ultrafiltration

Indexed keywords

COLLAGEN TYPE 1; DIALYSIS FLUID; GLUCOSE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; FIBROSIS; MALE; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ULTRAFILTRATION;

ANIMALS; DIALYSIS SOLUTIONS; FIBROSIS; MALE; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 48249109924     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142529     Document Type: Article

References (28)

1. Locatelli F, Pozzoni P, Del Vecchio L: Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 2004;15(suppl 1):S25-S29.
2. Welten AG, Schalkwijk CG, ter Wee PM, Meijer S, et al: Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit Dial Int 2003;23:213-221.
3. Yao Q, Ayala ER, Qian JQ, Stenvinkel P, et al: A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells. Clin Nephrol 2007;68:295-301.
4. Zeier M, Schwenger V, Deppisch R, Haug U, et al: Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003;63:298-305.
5. Margetts PJ, Bonniaud P: Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003;23:530-541.
6. Ha H, Yu MR, Lee HB: High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001;59:463-470.
7. Lin CY, Chen WP, Fu LW, Yang LY, et al: Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Adv Perit Dial 1997;13:64-71.
8. Lai KN, Lai KB, Szeto CC, Lam CW, et al: Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes. Am J Nephrol 1999;19:416-422.
9. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
10. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, et al: Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 2002;62:901-913.
11. Rougier JP, Guia S, Hagege J, Nguyen G, et al: PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1. Kidney Int 1998;54:87-98.
12. Martin J, Yung S, Robson RL, Steadman R, et al: Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int 2000;20:524-533.
13. Margetts PJ, Kolb M, Galt T, Hoff CM, et al: Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001;12:2029-2039.
14. Yao Q, Qian JQ, Lin XH, Lindholm B: Inhibition of the effect of high glucose on the expression of Smad in human peritoneal mesothelial cells. Int J Artif Organs 2004;27:828-834.
15. Li JH, Huang XR, Zhu HJ, Johnson R, et al: Role of TGF-beta signaling in extracellular matrix production under high glucose conditions. Kidney Int 2003;63:2010-2019.
16. Witowski J, Korybalska K, Ksiazek K, Wisniewska-Elnur J, et al: Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 2004;19:917-924.
17. Pawlaczyk K, Kuzlan-Pawlaczyk M, Wieczorowska-Tobis K, Polubinska A, et al: Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats. Perit Dial Int 1999;19(suppl 2):S370-S377.
18. Yao Q, Pawlaczyk K, Ayala ER, Kuzlan M, et al: Peroxisome proliferator-activated receptor-gamma agonists diminish peritoneal functional and morphological changes induced by bioincompatible peritoneal dialysis solution. Blood Purif 2006;24:575-582.
19. Williams JD, Craig KJ, Topley N, Von Ruhland C, et al: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470-479.
20. Williams JD, Craig KJ, Von Ruhland C, Topley N, et al: The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int 2003;64:S43-S49.
21. Poncelet AC, de Caestecker MP, Schnaper HW: The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 1999;56:1354-1365.
22. Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, et al: Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001;276:38527-38535.
23. Varga J: Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 2002;46:1703-1713.
24. Cooker LA, Luneburg P, Holmes CJ, Jones S, et al: Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions. Perit Dial Int 2001; 21(suppl 3):S102-S107.
25. Rashid G, Luzon AA, Korzets Z, Klein O, et al: The effect of advanced glycation end-products and aminoguanidine on TNFalpha production by rat peritoneal macrophages. Perit Dial Int 2001;21:122-129.
26. Wang W, Huang XR, Li AG, Liu F, et al: Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005;16:1371-1383.
27. Lan HY, Mu W, Tomita N, Huang XR, et al: Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003;14:1535-1548.
28. Nie J, Hao W, Dou X, Wang X, et al: Effects of Smad7 overexpression on peritoneal inflammation in a rat peritoneal dialysis model. Perit Dial Int 2007;27:580-588.